| Schedule of Common Stock Reserved for Future Issuance |
As of June 30, 2026 and December 31, 2025, the Company had common stock reserved for future issuance as follows: | | | June 30, | | | December 31, | | | | | 2026 | | | 2025 | | | Outstanding and issued common stock options | | | 2,386,099 | | | | 2,246,206 | | | Outstanding and issued restricted stock units | | | 68,850 | | | | 198,900 | | | Outstanding and issued performance-based restricted stock units | | | — | | | | 20,000 | | | Shares issuable upon exercise of Public Warrants (1) | | | 499,986 | | | | 499,986 | | | Shares issuable upon exercise of Common Warrants | | | 12,345,707 | | | | 12,345,707 | | | Shares issuable upon exercise of Pre-Funded Warrants | | | 675,000 | | | | 675,000 | | | Shares available for grant under Equity Incentive Plans | | | 626,560 | | | | 843,360 | | | Shares available for grant under Employee Stock Purchase Plan | | | 907,844 | | | | 920,827 | | | Shares available for grant under 2022 Inducement Equity Incentive Plan | | | 193,002 | | | | 132,769 | | | Total shares of common stock reserved | | | 17,703,048 | | | | 17,882,755 | | | (1) | The Company has 4,999,863 outstanding warrants to purchase an aggregate of 499,986 shares of its common stock (the “Public Warrants”). A holder may purchase one share of the Company’s common stock for every ten Public Warrants at an exercise price of $115.00 per share. The Public Warrants are publicly traded and exercisable during the exercise period, which commenced on October 24, 2021 and ends on September 24, 2026, for cash or, in certain circumstances, on a cashless basis. The Public Warrants were reclassified to equity in January 2023. |
|